Fusobacterium nucleatum infection of colonic cells stimulates MUC2 mucin and tumor necrosis factor alpha

Infection and Immunity

Volumn 79, Issue 7, 2011, Pages 2597-2607

  Dharmani, Poonam ^a   Strauss, Jaclyn ^b   Ambrose, Christian ^b   Allen Vercoe, Emma ^b   Chadee, Kris ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 1BETA; INTESTINAL TREFOIL FACTOR; MUCIN 1; MUCIN 2; MUCIN 3; RESISTIN; TREFOIL FACTOR 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CELL INVASION; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; EPITHELIUM CELL; FEMALE; FUSOBACTERIUM INFECTION; FUSOBACTERIUM NUCLEATUM; HUMAN; HUMAN CELL; IRRITABLE COLON; MALE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT;

ADULT; ANIMALS; CELL LINE, TUMOR; COLON; CROHN DISEASE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FUSOBACTERIUM INFECTIONS; FUSOBACTERIUM NUCLEATUM; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; MUCIN-2; MUCINS; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79959438740     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05118-11     Document Type: Article

References (45)

1. Abraham, C., and J. H. Cho. 2009. Inflammatory bowel disease. N. Engl. J. Med. 361:2066-2078.
2. Ahn, D. H., et al. 2005. TNF-alpha activates MUC2 transcription via NFkappaB but inhibits via JNK activation. Cell Physiol. Biochem. 15:29-40.
3. Andoh, A., K. Kinoshita, I. Rosenberg, and D. K. Podolsky. 2001. Intestinal trefoil factor induces decay-accelerating factor expression and enhances the protective activities against complement activation in intestinal epithelial cells. J. Immunol. 167:3887-3893.
4. Andrianifahanana, M., N. Moniaux, and S. K. Batra. 2006. Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochim. Biophys. Acta 1765:189-222.
5. Behr, M. A., and V. Kapur. 2008. The evidence for Mycobacterium paratuberculosis in Crohn's disease. Curr. Opin. Gastroenterol. 24:17-21.
6. Belley, A., and K. Chadee. 1999. Prostaglandin E(2) stimulates rat and human colonic mucin exocytosis via the EP(4) receptor. Gastroenterology 117:1352-1362.
7. Belley, A., K. Keller, J. Grove, and K. Chadee. 1996. Interaction of LS174T human colon cancer cell mucins with Entamoeba histolytica: an in vitro model for colonic disease. Gastroenterology 111:1484-1492.
8. Brown, S. J., and L. Mayer. 2007. The immune response in inflammatory bowel disease. Am. J. Gastroenterol. 102:2058-2069.
9. Chadee, K., K. Keller, J. Forstner, D. J. Innes, and J. I. Ravdin. 1991. Mucin and nonmucin secretagogue activity of Entamoeba histolytica and cholera toxin in rat colon. Gastroenterology 100:986-997.
10. Citron, D. M. 2002. Update on the taxonomy and clinical aspects of the genus Fusobacterium. Clin. Infect. Dis. 35:S22-27.
11. Contractor, N. V., et al. 1998. Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitisfree gnotobiotic IL-2-deficient mice. J. Immunol. 160:385-394.
12. Desvaux, M., A. Khan, S. A. Beatson, A. Scott-Tucker, and I. R. Henderson. 2005. Protein secretion systems in Fusobacterium nucleatum: genomic identification of type 4 piliation and complete type V pathways brings new insight into mechanisms of pathogenesis. Biochim. Biophys. Acta 1713:92-112.
13. Dharmani, P., and K. Chadee. 2008. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key. Curr. Mol. Pharmacol. 1:195-212.
14. Dianda, L., et al. 1997. T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am. J. Pathol. 150:91-97.
15. Eckmann, L. 2006. Sensor molecules in intestinal innate immunity against bacterial infections. Curr. Opin. Gastroenterol. 22:95-101.
16. Einerhand, A. W., et al. 2002. Role of mucins in inflammatory bowel disease: important lessons from experimental models. Eur. J. Gastroenterol. Hepatol. 14:757-765.
17. Enss, M. L., et al. 2000. Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180. Inflamm Res. 49:162-169.
18. Gharbia, S. E., H. N. Shah, P. A. Lawson, and M. Haapasalo. 1990. Distribution and frequency of Fusobacterium nucleatum subspecies in the human oral cavity. Oral Microbiol. Immunol. 5:324-327.
19. Gmur, R., M. A. Munson, and W. G. Wade. 2006. Genotypic and phenotypic characterization of fusobacteria from Chinese and European patients with inflammatory periodontal diseases. Syst. Appl. Microbiol. 29:120-130.
20. Gmur, R., C. Wyss, Y. Xue, T. Thurnheer, and B. Guggenheim. 2004. Gingival crevice microbiota from Chinese patients with gingivitis or necrotizing ulcerative gingivitis. Eur. J. Oral Sci. 112:33-41.
21. Gottke, M., and K. Chadee. 1996. Exogenous nitric oxide stimulates mucin secretion from LS174T colonic adenocarcinoma cells. Inflamm. Res. 45:209-212.
22. Gui, G. P., et al. 1997. Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics. J. Antimicrob. Chemother. 39:393-400.
23. Han, Y. W., et al. 2000. Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect. Immun. 68:3140-3146.
24. Hogan, S. P., et al. 2006. Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility. J. Allergy Clin. Immunol. 118:257-268.
25. Iwashita, J., et al. 2003. mRNA of MUC2 is stimulated by IL-4, IL-13 or TNF-alpha through a mitogen-activated protein kinase pathway in human colon cancer cells. Immunol. Cell Biol. 81:275-282.
26. Kim, Y. D., et al. 2002. Interleukin-1beta induces MUC2 gene expression and mucin secretion via activation of PKC-MEK/ERK, and PI3K in human airway epithelial cells. J. Korean Med. Sci. 17:765-771.
27. Knight, P., B. J. Campbell, and J. M. Rhodes. 2008. Host-bacteria interaction in inflammatory bowel disease. Br. Med. Bull. 88:95-113.
28. Krimi, R. B., et al. 2008. Resistin-like molecule beta regulates intestinal mucous secretion and curtails TNBS-induced colitis in mice. Inflamm. Bowel Dis. 14:931-941.
29. Liu, H., R. W. Redline, and Y. W. Han. 2007. Fusobacterium nucleatum induces fetal death in mice via stimulation of TLR4-mediated placental inflammatory response. J. Immunol. 179:2501-2508.
30. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
31. Mashimo, H., D. C. Wu, D. K. Podolsky, and M. C. Fishman. 1996. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 274:262-265.
32. Minami, M., et al. 2009. Seroprevalence of Fusobacterium varium in ulcerative colitis patients in Japan. FEMS Immunol. Med. Microbiol. 56:67-72.
33. Oberhelman, H. A., Jr., S. Kohatsu, K. B. Taylor, and R. M. Kivel. 1968. Diverting ileostomy in the surgical management of Crohn's disease of the colon. Am. J. Surg. 115:231-240.
34. Ohkusa, T., et al. 2003. Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut 52:79-83.
35. Ohkusa, T., et al. 2009. Commensal bacteria can enter colonic epithelial cells and induce proinflammatory cytokine secretion: a possible pathogenic mechanism of ulcerative colitis. J. Med. Microbiol. 58:535-545.
36. Polak, D., et al. 2009. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response. J. Clin. Periodontol. 36:406-410.
37. Popoff, M. R. 2005. Bacterial exotoxins. Contrib. Microbiol. 12:28-54.
38. Rolhion, N., and A. Darfeuille-Michaud. 2007. Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm. Bowel Dis. 13:1277-1283.
39. Sellon, R. K., et al. 1998. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66:5224-5231.
40. Strauss, J., et al. 13 January 2011. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm. Bowel Dis. [Epub ahead of print] doi:10.1002/ibd.21606.
41. Strauss, J., A. White, C. Ambrose, J. McDonald, and E. Allen-Vercoe. 2008. Phenotypic and genotypic analyses of clinical Fusobacterium nucleatum and Fusobacterium periodonticum isolates from the human gut. Anaerobe 14: 301-309.
42. Sutherland, L., et al. 1991. Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut 32:1071-1075.
43. Swidsinski, A., et al. 2011. Acute appendicitis is characterized by local invasion with Fusobacterium nucleatum/necrophorum. Gut 60:34-40.
44. Taupin, D., and D. K. Podolsky. 2003. Trefoil factors: initiators of mucosal healing. Nat. Rev. Mol. Cell Biol. 4:721-732.
45. Tse, S. K., and K. Chadee. 1992. Biochemical characterization of rat colonic mucins secreted in response to Entamoeba histolytica. Infect. Immun. 60: 1603-1612.